Protalix BioTherapeutics

Protalix BioTherapeutics revenue

Annual Revenue ($)

Protalix BioTherapeutics revenue was $54.69 m in FY, 2019

Quarterly Revenue ($)

	FY, 2011	FY, 2012	FY, 2013	FY, 2014	FY, 2015	FY, 2016	FY, 2017	FY, 2019
Revenue	$8.39 m	$34.87 m	$10.48 m	$13.65 m	$4.36 m	$9.2 m	$19.24 m	$54.69 m

	Q2, 2011	Q3, 2011	Q1, 2012	Q2, 2012	Q3, 2012	Q1, 2013	Q2, 2013	Q3, 2013	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017	Q3, 2017	Q1, 2018	Q2, 2018	Q3, 2018	Q1, 2020	Q2, 2020	Q3, 2020
Revenue	$764 k	$1.13 m	$3.86 m	$26.11 m	$3.72 m	$3.57 m	$2.26 m	$2.28 m	$2.43 m	$2.4 m	$4.39 m	$3.78 m	$679 k	$1.77 m	$4.67 m	$2.89 m	$6.36 m	$7.53 m	$4.55 m	$2.01 m	$663 k	$21.65 m	$10.97 m	$10.79 m

View all financials

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.